Tacrolimus
NDC 14789-135, Tacrolimus, injection, from Nexus Pharmaceuticals, LLC.
- Product NDC
- 14789-135
- Status
- Listed
- Labeler
- Nexus Pharmaceuticals, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217108
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/14789-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TACROLIMUS5 mg/mL
Pharmacologic classes
Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 14789-135-05 | 14789013505 | 10 VIAL in 1 CARTON (14789-135-05) / 1 mL in 1 VIAL (14789-135-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9d502961-e9c0-4611-92bf-ce742a7b962cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=14789-135
Use it
Look up 14789-135 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/14789-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 14789-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.